These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 25695542)
1. The expression of tumor-derived and stromal-derived matrix metalloproteinase 2 predicted prognosis of ovarian cancer. Fu Z; Xu S; Xu Y; Ma J; Li J; Xu P Int J Gynecol Cancer; 2015 Mar; 25(3):356-62. PubMed ID: 25695542 [TBL] [Abstract][Full Text] [Related]
2. Limited independent prognostic value of MMP-14 and MMP-2 expression in ovarian cancer. Vos MC; van der Wurff AA; Bulten J; Kruitwagen R; Feijen H; van Kuppevelt TH; Hendriks T; Massuger LF Diagn Pathol; 2016 Apr; 11():34. PubMed ID: 27038607 [TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of stromal metalloproteinase-2 in ovarian adenocarcinoma and its relation to carcinoma progression. Torng PL; Mao TL; Chan WY; Huang SC; Lin CT Gynecol Oncol; 2004 Feb; 92(2):559-67. PubMed ID: 14766248 [TBL] [Abstract][Full Text] [Related]
4. Correlation of tumor- and stromal-derived MT1-MMP expression with progression of human ovarian tumors in SCID mice. Drew AF; Blick TJ; Lafleur MA; Tim EL; Robbie MJ; Rice GE; Quinn MA; Thompson EW Gynecol Oncol; 2004 Dec; 95(3):437-48. PubMed ID: 15581944 [TBL] [Abstract][Full Text] [Related]
5. Pathological and prognostic significance of matrix metalloproteinase-2 expression in ovarian cancer: a meta-analysis. Liu C Clin Exp Med; 2016 Aug; 16(3):375-82. PubMed ID: 26123901 [TBL] [Abstract][Full Text] [Related]
6. Prognostic value of MMP-9 in ovarian cancer: a meta-analysis. Li LN; Zhou X; Gu Y; Yan J Asian Pac J Cancer Prev; 2013; 14(7):4107-13. PubMed ID: 23991961 [TBL] [Abstract][Full Text] [Related]
7. Prognostic value of MMP-2 for patients with ovarian epithelial carcinoma: a systematic review and meta-analysis. Jia H; Zhang Q; Liu F; Zhou D Arch Gynecol Obstet; 2017 Mar; 295(3):689-696. PubMed ID: 27995372 [TBL] [Abstract][Full Text] [Related]
8. Expression of latent matrix metalloproteinase 9 (MMP-9) predicts survival in advanced ovarian cancer. Lengyel E; Schmalfeldt B; Konik E; Späthe K; Härting K; Fenn A; Berger U; Fridman R; Schmitt M; Prechtel D; Kuhn W Gynecol Oncol; 2001 Aug; 82(2):291-8. PubMed ID: 11531282 [TBL] [Abstract][Full Text] [Related]
9. The impact of matrix metalloproteinase 2 on prognosis and clinicopathology of breast cancer patients: a systematic meta-analysis. Chen Y; Wang X; Chen G; Dong C; Zhang D PLoS One; 2015; 10(3):e0121404. PubMed ID: 25816052 [TBL] [Abstract][Full Text] [Related]
10. Role of immunohistochemical overexpression of matrix metalloproteinases MMP-2 and MMP-11 in the prognosis of death by ovarian cancer. Périgny M; Bairati I; Harvey I; Beauchemin M; Harel F; Plante M; Têtu B Am J Clin Pathol; 2008 Feb; 129(2):226-31. PubMed ID: 18208802 [TBL] [Abstract][Full Text] [Related]
11. The correlation between immunohistochemical expression of MMP-2 and the prognosis of epithelial ovarian cancer. Ekinci T; Ozbay PO; Yiğit S; Yavuzcan A; Uysal S; Soylu F Ginekol Pol; 2014 Feb; 85(2):121-30. PubMed ID: 24745158 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of MMP Family Members Functions as Prognostic Biomarker for Breast Cancer Patients: A Systematic Review and Meta-Analysis. Ren F; Tang R; Zhang X; Madushi WM; Luo D; Dang Y; Li Z; Wei K; Chen G PLoS One; 2015; 10(8):e0135544. PubMed ID: 26270045 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of matrix metalloproteinase 9 expression in breast cancer patients: a meta-analysis. Song J; Su H; Zhou YY; Guo LL Asian Pac J Cancer Prev; 2013; 14(3):1615-21. PubMed ID: 23679245 [TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of extracellular matrix metalloproteinase inducer and matrix metalloproteinase 2 in epithelial ovarian cancer. Sillanpää S; Anttila M; Suhonen K; Hämäläinen K; Turpeenniemi-Hujanen T; Puistola U; Tammi M; Sironen R; Saarikoski S; Kosma VM Tumour Biol; 2007; 28(5):280-9. PubMed ID: 17962725 [TBL] [Abstract][Full Text] [Related]
15. Differential expression of matrix metalloproteinase (MMP)-2, MMP-9, and membrane type 1-MMP in hepatocellular and pancreatic adenocarcinoma: implications for tumor progression and clinical prognosis. Määttä M; Soini Y; Liakka A; Autio-Harmainen H Clin Cancer Res; 2000 Jul; 6(7):2726-34. PubMed ID: 10914717 [TBL] [Abstract][Full Text] [Related]
16. Prognostic value of matrix metalloproteinase-9 (gelatinase-B) expression in epithelial ovarian tumors. Ozalp S; Tanir HM; Yalcin OT; Kabukcuoglu S; Oner U; Uray M Eur J Gynaecol Oncol; 2003; 24(5):417-20. PubMed ID: 14584660 [TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of TIMP-2, MMP-2, and MMP-9 on high-grade serous ovarian carcinoma using digital image analysis. Desmeules P; Trudel D; Turcotte S; Sirois J; Plante M; Grégoire J; Renaud MC; Orain M; Têtu B; Bairati I Hum Pathol; 2015 May; 46(5):739-45. PubMed ID: 25771900 [TBL] [Abstract][Full Text] [Related]
18. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance]. Hu XX; Li L; Li DR; Zhang W; Cheng XQ; Zhang JQ; Tang BJ Ai Zheng; 2004 Oct; 23(10):1194-8. PubMed ID: 15473934 [TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of MMP-7 expression in colorectal cancer: a meta-analysis. Sun DW; Zhang YY; Qi Y; Zhou XT; Lv GY Cancer Epidemiol; 2015 Apr; 39(2):135-42. PubMed ID: 25677090 [TBL] [Abstract][Full Text] [Related]
20. Visual and automated assessment of matrix metalloproteinase-14 tissue expression for the evaluation of ovarian cancer prognosis. Trudel D; Desmeules P; Turcotte S; Plante M; Grégoire J; Renaud MC; Orain M; Bairati I; Têtu B Mod Pathol; 2014 Oct; 27(10):1394-404. PubMed ID: 24603589 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]